Telemedicine Treatment for Veterans With Gulf War Illness

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Department of Veterans Affairs
ClinicalTrials.gov Identifier:
NCT00129454
First received: August 9, 2005
Last updated: April 18, 2013
Last verified: October 2008
  Purpose

Effective treatments have been developed to ameliorate symptom-related distress and reduce unnecessary healthcare utilization using cognitive-behavioral techniques (CBT) . Despite convincing evidence of therapeutic efficacy, a major limitation of this treatment is that patients must attend sessions in person. The specific aims of the study are to: (1) Determine the clinical efficacy of Telephone CBT for veterans with GWI who are frequent consumers of ambulatory medical care; (2) Determine whether CBT for veterans with GWI leads to a reduction in the cost of VA health care; and (3) Develop a statistical model of treatment seeking in veterans with GWI who are frequent consumers of ambulatory medical care.


Condition Intervention
Gulf War Syndrome
Behavioral: Cognitive Behavioral Therapy

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Factorial Assignment
Masking: Open Label
Official Title: Telemedicine Treatment for Veterans With Gulf War Illness

Further study details as provided by Department of Veterans Affairs:

Primary Outcome Measures:
  • Frequency of medical visitation [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • quality of life [ Designated as safety issue: No ]

Enrollment: 128
Study Start Date: September 2005
Study Completion Date: March 2008
Primary Completion Date: February 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Arm 1 Behavioral: Cognitive Behavioral Therapy

  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Top 20% of medical care utilizers;
  • Satisfies criteria for multisymptom illness;
  • Enrolled in the New Jersey VA Healthcare System for at least one year

Exclusion Criteria:

  • Psychotic disorders;
  • Dementia or other cognitive disorders;
  • Brain damage;
  • Anorexia/other eating disorders;
  • Pregnancy;
  • Heart failure;
  • Cancer;
  • Chronic renal insufficiency;
  • Severe hepatic disease;
  • Active Substance Abuse/Dependence
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00129454

Locations
United States, New Jersey
VA New Jersey Health Care System, East Orange
East Orange, New Jersey, United States, 07018
Sponsors and Collaborators
Investigators
Principal Investigator: Mia M Downing, PhD VA New Jersey Health Care System (East Orange)
  More Information

No publications provided

Responsible Party: Department of Veterans Affairs
ClinicalTrials.gov Identifier: NCT00129454     History of Changes
Other Study ID Numbers: GWI 04-355
Study First Received: August 9, 2005
Last Updated: April 18, 2013
Health Authority: United States: Federal Government

Keywords provided by Department of Veterans Affairs:
Telemedicine
Cognitive Behavior Therapy
Utilization
Randomized Control Trial
Gulf War Illness
Symptom-Based Illness
Multisymptom Illness
High utilization

Additional relevant MeSH terms:
Persian Gulf Syndrome
Occupational Diseases

ClinicalTrials.gov processed this record on April 16, 2014